- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07883473
Pudendal Nerve Block for Pain Relief During Episiotomy Repair
Pudendal Nerve Block for Pain Relief During Episiotomy Repair: A Randomized Controlled Trial
Episiotomy is a surgical cut made in the perineum, the area between the vagina and anus, during vaginal childbirth. Repairing an episiotomy can cause pain, and adequate pain relief is important for maternal comfort during and after delivery.
This study will compare two methods of providing anesthesia during episiotomy repair in women undergoing vaginal delivery with a mediolateral episiotomy at the Department of Maternal and Child Health (MCH), Pakistan Institute of Medical Sciences (PIMS), Islamabad, Pakistan.
A total of 80 eligible women will be enrolled and randomly assigned in equal numbers to two groups. The intervention group will receive a bilateral pudendal nerve block in addition to routine episiotomy repair and standard postpartum pain relief. The control group will receive conventional local anesthetic infiltration around the episiotomy area, along with routine repair and standard postpartum pain relief.
Pain will be assessed using a 100-mm Visual Analogue Scale (VAS), on which 0 represents no pain and 100 represents the worst imaginable pain. Pain will be assessed during episiotomy repair and at 1, 3, and 6 hours after delivery.
The study will also compare the need for additional pain medication, pain during sitting and walking, patient comfort and satisfaction, the duration of episiotomy repair, the need for additional local anesthetic, and complications associated with the procedures.
The aim is to determine whether pudendal nerve block provides better pain relief during episiotomy repair and improves early postpartum comfort compared with conventional local anesthetic infiltration.
Visão geral do estudo
Status
Condições
Descrição detalhada
Episiotomy is a surgical incision of the perineum performed during vaginal delivery and may be associated with pain during repair and in the early postpartum period. Conventional local perineal infiltration is commonly used to provide anesthesia during episiotomy repair; however, adequate pain relief may not always be achieved.
The pudendal nerve supplies sensory innervation to the vulva, lower vagina, perineum, and anus. Pudendal nerve block is a regional anesthetic technique that may provide effective analgesia during episiotomy repair. This study will evaluate the effectiveness of pudendal nerve block compared with conventional local perineal infiltration in women undergoing mediolateral episiotomy at the Department of Maternal and Child Health, Pakistan Institute of Medical Sciences (MCH PIMS), Islamabad.
Eligible women aged 18 years or older who undergo vaginal delivery with mediolateral episiotomy will be recruited after eligibility assessment and informed consent. Participants will be randomly allocated to one of two groups. The intervention group will receive bilateral pudendal nerve block using 2% lidocaine, in addition to routine episiotomy repair and standard postpartum analgesia. The control group will receive conventional local perineal infiltration according to the institutional protocol. Both groups will receive routine episiotomy repair and standard postpartum analgesia.
Pain intensity will be assessed using a 100-mm Visual Analogue Scale during episiotomy repair and at 1, 3, and 6 hours postpartum. Additional assessments will include the need for rescue analgesia, pain during sitting and walking, patient-reported comfort and satisfaction, duration of repair, requirement for additional local anesthetic, and the success or failure of the nerve block. Adverse events and complications associated with the procedures will also be documented.
The study aims to determine whether pudendal nerve block improves pain relief during episiotomy repair and early postpartum comfort compared with conventional local perineal infiltration. The findings may contribute to the local evidence base for pain management during episiotomy repair.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Zeenat Usman/Medical officier, MS obstetrics and gyanecology
- Número de telefone: +923315333910
- E-mail: usmanbut2@gmail.com
Estude backup de contato
- Nome: Sobia Luqman/Assisstant Professor, FCPS obstetrics and gyane
- Número de telefone: +923348626904
- E-mail: sobialuqman8@gmail.com
Locais de estudo
-
-
ICT
-
Islamabad, ICT, Paquistão, 04485
- Department of Maternal and Child Health (MCH), Pakistan Institute of Medical Sciences (PIMS)
-
Contato:
- Zeenat Usman, MS obstetrics and Gyanecology
- Número de telefone: +923315333910
- E-mail: usmanbut2@gmail.com
-
Contato:
- Sobia Luqman, FCPS obstetrics and gyanecolog
- Número de telefone: +923348626904
- E-mail: sobialuqman8@gmail.com
-
Investigador principal:
- Zeenat Usman, Ms Obsterics and gyanecology
-
Subinvestigador:
- Sobia Luqman, FCPS-obstertics and gyanecolog
-
Subinvestigador:
- Lubaba Tahir
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Women aged 18 years or older
- Singleton pregnancy
- Vaginal delivery at MCH PIMS
- Requirement for mediolateral episiotomy
- Clinically uncomplicated episiotomy requiring routine repair
- Ability to understand the study information and provide written informed consent
Exclusion Criteria:
- Allergy or contraindication to the proposed local anesthetic
- Known coagulation disorder or significant bleeding tendency
- Local infection at the proposed injection site
- Associated third- or fourth-degree perineal tear
- Extensive vaginal or cervical laceration requiring additional anesthesia
- Major postpartum hemorrhage or another major postpartum complication requiring urgent management
- Chronic pelvic or perineal pain, or regular use of analgesic medication before delivery
- Inability to understand the pain assessment scale or provide informed consent
- Failed pudendal nerve block despite appropriate technique
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Pudendal Nerve Block Group
Participants will receive bilateral pudendal nerve block using 2% lidocaine, 2 mL, as specified in the study protocol. The procedure will be performed by an appropriately trained obstetrician or anesthetist using a standardized technique. Routine episiotomy repair and standard postpartum analgesia will also be provided. |
Bilateral pudendal nerve block performed using the standardized technique specified in the study protocol, with the local anesthetic described in the protocol (2% lidocaine, 2 mL). The procedure will be performed by an appropriately trained obstetrician or anesthetist, in addition to routine episiotomy repair and standard postpartum analgesia. Local anesthetic administered for bilateral pudendal nerve block at a dose of 2 mL, as specified in the study protocol. |
|
Comparador Ativo: Conventional Local Infiltration Group
Participants will receive conventional local perineal infiltration anesthesia according to the standard MCH PIMS episiotomy-repair protocol. Routine episiotomy repair and standard postpartum analgesia will be provided. |
Conventional local anesthetic infiltration around the episiotomy site according to the standard MCH PIMS episiotomy-repair protocol. Routine episiotomy repair and standard postpartum analgesia will also be provided. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Pain intensity during episiotomy repair
Prazo: During episiotomy repair
|
Pain intensity will be measured using a 100-mm Visual Analogue Scale (VAS), where 0 represents no pain and 100 mm represents the worst imaginable pain. Pain will be assessed at predefined stages during episiotomy repair, including after anesthesia administration, at commencement of repair, during repair, and at completion of repair. |
During episiotomy repair
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Postpartum pain intensity
Prazo: 1, 3, and 6 hours postpartum
|
pain intensity measured using a 100-mm Visual Analogue Scale (VAS), where 0 represents no pain and 100 represents the worst imaginable pain. |
1, 3, and 6 hours postpartum
|
|
Requirement for rescue analgesia
Prazo: First 6 hours postpartum
|
Proportion of participants requiring additional analgesic medication for inadequate episiotomy-related pain relief. |
First 6 hours postpartum
|
|
Patient satisfaction with pain management
Prazo: 1-6 hours postpartum
|
Patient satisfaction with pain management assessed using a 5-point Likert scale, ranging from very dissatisfied to very satisfied. |
1-6 hours postpartum
|
Colaboradores e Investigadores
Patrocinador
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- F.1-1/2015/ERB/SZABMU/1634
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
De-identified individual participant data collected during this study will not be shared with researchers outside the study team. Study data will be used for the planned analyses and reporting of study findings.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .